At the news
? NEUTRALIMPACT 3/10 144 filed Nov 12, 2026 at 17:59 ET
Samsara BioCapital, L.P., a significant shareholder in Septerna, filed a Form 144 notice of intent to sell 306,645 shares of common stock, with an approximate market value of $14.9 million. This represents a notable insider sale by a pre-IPO investor, though it is only an intent to sell and may not be executed.
- Samsara BioCapital, L.P. filed Form 144 on November 12, 2026
- Proposed sale of 306,645 shares of Septerna common stock
- Estimated aggregate market value of $14,890,681.20 based on a price of $48.55 per share
- Shares were acquired on October 25, 2024 in the IPO
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access